OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Franziska M. Wuerfel, Hanna Huebner, Lothar Häberle, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Deregulation of HLA-I in cancer and its central importance for immunotherapy
Ahmet Hazini, Kerry Fisher, Leonard W. Seymour
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002899-e002899
Open Access | Times Cited: 138

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45

Integrative HLA typing of tumor and adjacent normal tissue can reveal insights into the tumor immune response
Angelina Sverchkova, Scott Burkholz, Reid Rubsamen, et al.
BMC Medical Genomics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4

HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation
Burcu Duygu, Timo I. Olieslagers, Mathijs Groeneweg, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24

Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows
Sarah Lehle, Julius Emons, Carolin C. Hack, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9

Induction of pulmonary HLA-G expression by SARS-CoV-2 infection
Barbara Seliger, Simon Jasinski‐Bergner, Chiara Massa, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Open Access | Times Cited: 14

Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer
Michał Marczyk, Tao Qing, Tess A. O’Meara, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 13

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
Peilong Li, Nan Wang, Yi Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16

Exploring ceRNA networks for key biomarkers in breast cancer subtypes and immune regulation
Alireza Shariatmadar Taleghani, Yasaman Zohrab Beigi, Fatemeh Zare‐Mirakabad, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4

HLA-G - evolvement from a trophoblast specific marker to a checkpoint molecule in cancer, a narrative review about the specific role in breast- and gynecological cancer
Julia Knabl, Ye Yao, Gernot Desoyé, et al.
Journal of Reproductive Immunology (2024) Vol. 166, pp. 104385-104385
Open Access | Times Cited: 1

A comprehensive pancancer analysis reveals the potential value of RAR-related orphan receptor C (RORC) for cancer immunotherapy
Shengfu He, Jiawen Yu, Weijie Sun, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 5

Diversity in the HLA-I Recognition of HLA-F Monoclonal Antibodies: HLA-F or HLA-Ib Monospecific, HLA-E or HLA-G Bispecific Antibodies with or without HLA-Ia Reactivity
Mepur H. Ravindranath, Narendranath M. Ravindranath, Carly J. Amato-Menker, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 8-8
Open Access

Immunomodulatory Gene-Splicing Dysregulation in Tumorigenesis: Unmasking the Complexity
Lorraine Tshegofatso Maebele, Thanyani Victor Mulaudzi, Madhavan Yasasve, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 5984-5984
Open Access | Times Cited: 1

Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity
Ion G. Motofei
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 5, pp. 599-612
Closed Access | Times Cited: 3

HLA-G: A Novel Immune Checkpoint for Solid Cancer Immunotherapy
Aifen Lin, Wei‐Hua Yan
Springer eBooks (2023), pp. 1-27
Closed Access

Page 1

Scroll to top